Lung Cancer: Targets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 52.9% | 1.028 | Q2 | 84.6% |
| 2024 | 3.3 | Q2 | 62.6% | 1.415 | Q1 | 91.4% |
| 2023 | 5.1 | Q1 | 77.0% | 0.979 | Q2 | 85.0% |
| 2022 | 3.6 | 54.5% | 0.863 | Q2 | 82.6% | |
| 2021 | — | 25.2% | 1.056 | Q2 | 87.6% | |
| 2020 | — | — | 1.433 | Q1 | 91.8% | |
| 2019 | — | — | 1.323 | Q2 | 90.8% | |
| 2018 | — | — | 0.768 | Q3 | 77.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1179-2728
region
Pacific Region
coverage
2010-2026